Latest Non-Hodgkin lymphoma Stories
LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
SEATTLE, July 21, 2014 /PRNewswire/ -- CTI BioPharma Corp.
-COMMUNITY LEADERS RAISED $30.5 MILLION TO HELP FIND CANCER CURES- WHITE PLAINS, N.Y., July 17, 2014 /PRNewswire/ -- A Chicago man and Los Angeles woman raised $386,284 and $343,962,
Failure to get the best treatment and variations in the quality of care are the most likely reasons why survival for blood cancer patients still varies widely between regions within Europe.
HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients.
MabThera SC offers a faster administration time for patients in Europe while potentially saving valuable time for health systems SAN DIEGO, June 25, 2014 /PRNewswire/ -- Halozyme Therapeutics,
CAMBRIDGE, Mass., June 10, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company
Follicular lymphoma, a B cell lymphoma, is an incurable form of non-Hodgkin lymphoma that is diagnosed each year in 120,000 people worldwide.
Transparency Market Research added a new report "Global Natural Killer Cell Lymphomas Market: Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store.
Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., May 15, 2014 /PRNewswire-iReach/ -- In his new book,
- To fire mitraille at.